De-nest and present fragile filled glass syringes/vials in aseptic fill-finish

In Bayer's parenteral/biologic fill-finish lines (e.g., Eylea aflibercept, supplied in a type I glass pre-filled syringe with elastomeric plunger stopper and Luer-lock tip cap), thin-walled glass primary containers must be removed from nests/trays, oriented, and presented for filling, stoppering and inspection. The objects are small, slippery, optically clear, breakable, and arrive at high throughput inside a Grade A aseptic isolator where human intervention is minimized to protect sterility. The manipulation sequence involves singulating from a nest, lifting without glass-to-glass clink, holding under fill, and transferring to inspection without scuffing or microcracking. It is hard for a robot because vision struggles with transparent glass and cannot sense incipient contact force, and because any particle generation or container breach in the sterile zone is unrecoverable. Throughput figures are not public, but Eylea is a high-volume, high-value franchise where rejected units are expensive. We identified this through our own research; we have not confirmed the specifics with the customer directly. This page is our researched read — a starting point for that conversation.